Biosimilars: The strategic leap in clinical research and access to biological therapies
Over the past two decades, biological medicines have transformed the treatment of chronic and complex diseases such as cancer, rheumatoid arthritis, and diabetes. However, the high cost of these therapies has limited access for millions of patients worldwide, placing pressure on public and private healthcare systems. In this context, biosimilars – medicines that are […]
From Lab to Market: Why Brazil Is a Strategic Hub for Global Clinical Trials
As the global pharmaceutical landscape becomes more competitive and complex, sponsors face growing pressure to identify markets that can accelerate development timelines without compromising data quality or regulatory standards. Brazil is establishing itself as a strategic hub for global clinical trials, offering a powerful combination of scientific excellence, operational efficiency, and access to a […]